2019 Germany Drugs of Abuse Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers - ResearchAndMarkets.com

This new 262-page report from the author provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, Technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, May 7, 2019
Information
Tags: 
Health, Other Health, Business, Microeconomics, Market economics), Marketing, Assay, Biochemistry, Titration, Market segmentation, Forecasting, Market share, Drug test
Geotags: 
Europe, Germany
⚠generated by AI ↴
Summary
Key Points: 
  • This new 262-page report from the author provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, Technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
  • The report provides test volume and sales forecasts by country and market segment for the following assays:
    During the next five years, the abused drug testing market will undergo significant transformation.
  • This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses.
  • The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.


The "2019
Germany Drugs of Abuse Testing Market Shares, Segmentation Forecasts,
Competitive Landscape, Innovative Technologies, Latest Instrumentation,
Opportunities for Suppliers" report has been added to ResearchAndMarkets.com's
offering.

This new 262-page report from the author provides a comprehensive
analysis of the German drug of abuse testing market, including emerging
tests, Technologies, instrumentation, sales forecasts, market shares,
and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country
and market segment for the following assays:

Amphetamines, Antidepressants, Barbiturates, Benzodiazepines,
Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates,
Phencyclidine (PCP), Propoxphene.

During the next five years, the abused drug testing market will undergo
significant transformation. These changes will be caused by convergence
of new and more stringent regulations; advances in diagnostic
Technologies, system engineering, automation, and IT; and intensifying
competition. Some segments will start resembling commodity markets,
where product positioning and cost per test are more critical than
underlying technology. This evolving marketplace will create exciting
opportunities for a variety of new instruments, reagent systems, and
auxiliary products, such as specimen preparation devices, controls,
calibrators and others.

This report is a unique study designed to help current suppliers and
potential market entrants identify and evaluate emerging opportunities
and developed effective strategic responses. The study explores future
trends; and provides test volume and sales forecasts, by market segment
and individual assay.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • bioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory/Werfen
  • Kyowa Medex
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Quest Diagnostics
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako

For more information about this report visit https://www.researchandmarkets.com/r/czee86

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

Copyright: 
Copyright Business Wire 2019